The selective noradrenergic reuptake inhibitor reboxetine restores spatial learning deficits, biochemical changes, and hippocampal synaptic plasticity in an animal model of depression

Journal of Neuroscience Research

Volumn 93, Issue 1, 2015, Pages 104-120

  Bhagya, V ^a   Srikumar, B N ^a   Raju, T R ^a   Shankaranarayana Rao, B S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Cognitive deficits; Depression; Long term potentiation; Noradrenergic dysfunction; Synaptic plasticity

Indexed keywords

ACETYLCHOLINESTERASE; ANTIDEPRESSANT AGENT; DOPAMINE; MONOAMINE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; REBOXETINE; SEROTONIN; BIOGENIC AMINE; MORPHOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN SLICE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DRUG DOSE COMPARISON; DRUG EFFECT; ELECTRIC POTENTIAL; ENZYME ACTIVITY; ENZYME ASSAY; FORCED SWIM TEST; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; LEARNING; LONG TERM POTENTIATION; MALE; MEMORY; MEMORY DISORDER; MENTAL DISEASE; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RADIAL ARM MAZE TEST; RAT; SPATIAL LEARNING; SUCROSE PREFERENCE TEST; TASK PERFORMANCE; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ELECTROSTIMULATION; FEMALE; FOOD PREFERENCE; IN VITRO STUDY; LEARNING DISORDERS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; SWIMMING; WISTAR RAT;

ACETYLCHOLINESTERASE; ANIMALS; ANIMALS, NEWBORN; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; DEPRESSION; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; FEMALE; FOOD PREFERENCES; HIPPOCAMPUS; IN VITRO TECHNIQUES; LEARNING DISORDERS; MALE; MORPHOLINES; NEURONAL PLASTICITY; RATS; RATS, WISTAR; SPATIAL LEARNING; SWIMMING;

EID: 84923559404     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23473     Document Type: Article

References (122)

1. Almaguer-Melian W, Rojas-Reyes Y, Alvare A, Rosillo JC, Frey JU, Bergado JA. 2005. Long-term potentiation in the dentate gyrus in freely moving rats is reinforced by intraventricular application of norepinephrine, but not oxotremorine. Neurobiol Learn Mem 83:72-78.
2. Anderson WW, Collingridge GL. 2001. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J Neurosci Methods 108:71-83.
3. Andreasen JT, Redrobe JP. 2008. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests. Behav Brain Res 197:150-156.
4. Anuradha H, Srikumar BN, Deepti Nair V, Shankaranarayana Rao BS, Lakshmana M. 2010. Restoration of acetylcholinesterase activity by Euphorbia in discrete brain regions of chronically stressed rats. Pharm Biol 48:499-503.
5. Baj G, D'Alessandro V, Musazzi L, Mallei A, Sartori CR, Sciancalepore M, Tardito D, Langone F, Popoli M, Tongiorgi E. 2012. Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacol 37:1600-1611.
6. Barbon A, Popoli M, La Via L, Moraschi S, Vallini I, Tardito D, Tiraboschi E, Musazzi L, Giambelli R, Gennarelli M, Racagni G, Barlati S. 2006. Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol Psychiatry 59:713-720.
7. Barbon A, Caracciolo L, Orlandi C, Musazzi L, Mallei A, La Via L, Bonini D, Mora C, Tardito D, Gennarelli M, Racagni G, Popoli M, Barlati S. 2011. Chronic antidepressant treatments induce a time-dependent upregulation of AMPA receptor subunit protein levels. Neurochem Int 59:896-905.
8. Bergado JA, Scherf T, Almaguer-Melian W, Frey S, López J, Frey JU. 2009. Stimulation of the nucleus raphe medialis modifies basal synaptic transmission at the dentate gyrus but not long-term potentiation or its reinforcement by stimulation of the basolateral amygdala. Neurosci Lett 464:179-183.
9. Bhagya V, Srikumar BN, Raju TR, Shankaranarayana Rao BS. 2008. Neonatal clomipramine induced endogenous depression in rats is associated with learning impairment in adulthood. Behav Brain Res 187:190-194.
10. Bhagya V, Srikumar BN, Raju TR, Shankaranarayana Rao BS. 2011. Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression. Psychopharmacology 214:477-494.
11. Bhagya V, Mahati K, Christofer T, Shilpa BM, Raju TR, Shankaranarayana Rao BS. 2012a. Assessment of anxiety and depressive behaviour in animal models of psychiatric disorders. In: Shankaranarayana Rao BS, editor. Neural basis of learning and memory. Bangalore: National Institute of Mental Health and Neuro Sciences. p 97-103.
12. Bhagya V, Christofer T, Mahati K, Shilpa BM, Srikumar BN, Raju TR, Bindu M Kutty, Shankaranarayana Rao BS. 2012b. Methods of assessment of learning and memory in rodents. In: Shankaranarayana Rao BS, editor. Neural basis of learning and memory. Bangalore: National Institute of Mental Health and Neuro Sciences. p. 84-96.
13. Bhagya V, Mahati K, Raju TR, Shankaranarayana Rao BS. 2012c. Estimation of neurotransmitters in the brain by chromatographic methods. In: Shankaranarayana Rao BS, editor. Neural basis of learning and memory. Bangalore: National Institute of Mental Health and Neuro Sciences. p. 66-76.
14. Blokland A, Lieben C, Deutz NE. 2002. Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J Psychopharmacol 16:39-49.
15. Bohnen NI, Kaufer DI, Hendrickson R, Constantine GM, Mathis CA, Moore RY. 2007. Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia. J Neurol Neurosurg Psychiatry 78:641-643.
16. Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L, Raiteri M, Racagni G, Popoli M. 2005. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 25:3270-3279.
17. Bonilla-Jaime H, Retana-Marquez S, Velazquez-Moctezuma J. 1998. Pharmacological features of masculine sexual behavior in an animal model of depression. Pharmacol Biochem Behav 60:39-45.
18. Cadeddu R, Ibba M, Sadile A, Carboni E. 2014. Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy? Psychopharmacology 231:1925-1933.
19. Campbell S, Macqueen G. 2004. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 29:417-426.
20. Castren E. 2004. Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4:58-64.
21. Chen HC, Chen DY, Chen CC, Liang KC. 2004. Pre- and post-training infusion of prazosin into the bed nucleus of the stria terminalis impaired acquisition and retention in a Morris water maze task. Chin J Physiol 47:49-59.
22. Christofer T, Bhagya V, Mahati K, Raju TR, Shankaranarayana Rao BS. 2012. Recording of extra cellular field potentials from the hippocampal slices. In: Shankaranarayana Rao BS, editor. Neural basis of learning and memory. Bangalore: National Institute of Mental Health and Neuro Sciences. p. 108-115.
23. Dazzi L, Seu E, Cherchi G, Biggio G. 2003. Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine. Eur J Pharmacol 476:55-61.
24. Detke MJ, Lucki I. 1996. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43-46.
25. Detke MJ, Rickels M, Lucki I. 1995. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121:66-72.
26. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
27. Feenstra MG, Van Galen H, Te Riele PJ, Botterblom MH, Mirmiran M. 1996. Decreased hypothalamic serotonin levels in adult rats treated neonatally with clomipramine. Pharmacol Biochem Behav 55:647-652.
28. Feng P, Huang C. 2013. Phospholipase D-mTOR signaling is compromised in a rat model of depression. J Psychiatr Res 47:579-585.
29. Feng P, Guan Z, Yang X, Fang J. 2003. Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. Brain Res 991:195-205.
30. Feng P, Vurbic D, Wu Z, Hu Y, Strohl KP. 2008. Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. J Psychopharmacol 22:784-91.
31. Ferguson JM, Wesnes KA, Schwartz GE. 2003. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol 18:9-14.
32. Ferlemi AV, Avgoustatos D, Kokkosis AG, Protonotarios V, Constantinou C, Margarity M. 2014. Lead-induced effects on learning/memory and fear/anxiety are correlated with disturbances in specific cholinesterase isoform activity and redox imbalance in adult brain. Physiol Behav 131:115-122.
33. Frank MG, Heller HC. 1997. Neonatal treatments with the serotonin uptake inhibitors clomipramine and zimelidine, but not the noradrenaline uptake inhibitor desipramine, disrupt sleep patterns in adult rats. Brain Res 768:287-293.
34. Gao Y, Bezchlibnyk YB, Sun X, Wang JF, McEwen BS, Young LT. 2006. Effects of restraint stress on the expression of proteins involved in synaptic vesicle exocytosis in the hippocampus. Neuroscience 141:1139-1148.
35. Govindarajan A, Shankaranarayana Rao BS, Deepti N, Trinh M, Mawjee N, Tonegawa S, Chattarji S. 2006. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci U S A 103:13208-13213.
36. Grappi S, Nanni G, Leggio B, Rauggi R, Scheggi S, Masi F, Gambarana C. 2003. The efficacy of reboxetine in preventing and reverting a condition of escape deficit in rats. Biol Psychiatry 53:890-898.
37. Haider S, Saleem S, Perveen T, Tabassum S, Batool Z, Sadir S, Liaquat L, Madiha S. 2014. Age-related learning and memory deficits in rats: role of altered brain neurotransmitters, acetylcholinesterase activity and changes in antioxidant defense system. Age 36:9653.
38. Harkin A, Kelly JP, McNamara M, Connor TJ, Dredge K, Redmond A, Leonard BE. 1999. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol 364:123-132.
39. Herrmann N, Lanctot KL, Khan LR. 2004. The role of norepinephrine in the behavioral and psychological symptoms of dementia. J Neuropsychiatr Clin Neurosci 16:261-276.
40. Hu H, Real E, Takamiya K, Kang MG, Ledoux J, Huganir RL, Malinow R. 2007. Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell 131:160-173.
41. Invernizzi RW, Garattini S. 2004. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog Neuropsychopharmacol Biol Psychiatry 28:819-827.
42. Izumi Y, Zorumski CF. 1999. Norepinephrine promotes long-term potentiation in the adult rat hippocampus in vitro. Synapse 31:196-202.
43. Kehoe P, Hoffman JH, Austin-LaFrance RJ, Bronzino JD. 1995. Neonatal isolation enhances hippocampal dentate response to tetanization in freely moving juvenile male rats. Exp Neurol 136:89-97.
44. Kemp A, Manahan-Vaughan D. 2008. Beta-adrenoreceptors comprise a critical element in learning-facilitated long-term plasticity. Cereb Cortex 18:1326-1334.
45. Kerr JS, Powell J, Hindmarch I. 1996. The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Pharmacol 42:239-241.
46. Kinney GG, Vogel GW, Feng P. 1997. Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. Brain Res 756:68-75.
47. Kitchigina V, Vankov A, Harley C, Sara SJ. 1997. Novelty-elicited, noradrenaline-dependent enhancement of excitability in the dentate gyrus. Eur J Neurosci 9:41-47.
48. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA. 1997. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17:8451-8458.
49. Kojima T, Matsumoto M, Togashi H, Tachibana K, Kemmotsu O, Yoshioka M. 2003. Fluvoxamine suppresses the long-term potentiation in the hippocampal CA1 field of anesthetized rats: an effect mediated via 5-HT1A receptors. Brain Res 959:165-168.
50. Kosten TA, Galloway MP, Duman RS, Russell DS, D'Sa C. 2008. Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology 33:1545-1558.
51. Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE. 1997. Cognitive functions in major depression and Parkinson's disease. Arch Neurol 54:982-986.
52. Lagus M, Gass N, Saharinen J, Saarela J, Porkka-Heiskanen T, Paunio T. 2010. Gene expression patterns in a rodent model for depression. Eur J Neurosci 31:1465-1473.
53. Lambert G, Johansson M, Agren H, Friberg P. 2000. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry 57:787-793.
54. Lee KS, Na YG, Dean-McKinney T, Klausner AP, Tuttle JB, Steers WD. 2003. Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine. J Urol 170:2067-2071.
55. Linner L, Endersz H, Ohman D, Bengtsson F, Schalling M, Svensson TH. 2001. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J Pharmacol Exp Ther 297:540-546.
56. Linner L, Wiker C, Arborelius L, Schalling M, Svensson TH. 2004. Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain. J Neural Transm 111:127-139.
57. Mahati K, Bhagya V, Raju TR, Shankaranarayana Rao BS. 2012. Assay of acetylcholinesterase activity in the brain. In: Shankaranarayana Rao BS, editor. Neural basis of learning and memory. Bangalore: National Institute of Mental Health and Neuro Sciences. p 77-83.
58. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. 2000. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110.
59. Marcus MM, Jardemark K, Malmerfelt A, Björkholm C, Svensson TH. 2010. Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow, and NMDA receptor-mediated transmission. Neuropsychopharmacology 35:1952-1961.
60. Marvan ML, Chavez-Chavez L, Santana S. 1996. Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch Med Res 27:83-86.
61. Masana M, Bortolozzi A, Artigas F. 2011. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia. Int J Neuropsychopharmacol 14:53-68.
62. Mineur YS, Obayemi A, Wigestrand MB, Fote GM, Calarco CA, Li AM, Picciotto MR. 2013. Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behaviour. Proc Natl Acad Sci U S A 110:3573-3578.
63. Mori S, Popoli M, Brunello N, Racagni G, Perez J. 2001a. Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases. Neuropharmacology 40:448-456.
64. Mori K, Togashi H, Kojima T, Matsumoto M, Ohashi S, Ueno K, Yoshioka M. 2001b. Different effects of anxiolytic agents, diazepam, and 5-HT1A agonist tandospirone on hippocampal long-term potentiation in vivo. Pharmacol Biochem Behav 69:367-372.
65. Müller HK, Wegener G, Popoli M, Elfving B. 2011. Differential expression of synaptic proteins after chronic restraint stress in rat prefrontal cortex and hippocampus. Brain Res 1385:26-37.
66. Murphy P, Likhodii S, Nylen K, Burnham. 2004. The antidepressant properties of the ketogenic diet. Biol Psychiatry 56:981-983.
67. Nanjappa KN, Shalam MD, Harish MS, Prabhu BM, Shankaranarayana Rao BS, Kutty BM. 2007. Pharmacological and neurobiochemical evidence for antidepressant-like effect of Sumind: a herbal product in animals. Internet J Nutr Wellness 4 (http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijnw/vol4n1/Sumind.xml).
68. Nocjar C, Hammonds MD, Shim SS. 2007. Chronic lithium treatment magnifies learning in rats. Neuroscience 150:774-788.
69. Ordway GA. 1997. Pathophysiology of the locus coeruleus in suicide. Ann N Y Acad Sci 836:233-252.
70. Parini S, Renoldi G, Battaglia A, Invernizzi RW. 2005. Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus. Neuropsychopharmacology 30:1048-1055.
71. Pittaluga A, Raiteri L, Longordo F, Barbiero VS, Racagni G, Popoli M, Raiteri M. 2007. Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacol 53:27-36.
72. Porsolt RD, Anton G, Blavet N, Jalfre M. 1978. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391.
73. Prathiba J, Kumar KB, Karanth KS. 1995. Effects of neonatal clomipramine on cholinergic receptor sensitivity and passive avoidance behavior in adult rats. J Neural Transm 100:93-99.
74. Prathiba J, Kumar KB, Karanth KS. 1998. Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression. J Neural Transm 105:1335-1339.
75. Ramkumar K, Srikumar BN, Shankaranarayana Rao BS, Raju TR. 2008. Self-stimulation rewarding experience restores stress-induced CA3 dendritic atrophy, spatial memory deficits and alterations in the levels of neurotransmitters in the hippocampus. Neurochem Res 33:1651-1662.
76. Ravnkilde B, Videbech P, Clemmensen K, Egander A, Rasmussen NA, Rosenberg R. 2002. Cognitive deficits in major depression. Scand J Psychol 43:239-251.
77. Reid WM, Hamm RJ. 2008. Postinjury atomoxetine treatment improves cognition following experimental traumatic brain injury. J Neurotrauma 25:248-256.
78. Ressler KJ, Nemeroff CB. 2001. Role of norepinephrine in the pathophysiology of neuropsychiatric disorders. CNS Spectr 6:663-670.
79. Russo-Neustadt AA, Alejandre H, Garcia C, Ivy AS, Chen MJ. 2004. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 29:2189-2199.
80. Rygula R, Abumaria N, Havemann-Reinecke U, Rüther E, Hiemke C, Zernig G, Fuchs E, Flügge G. 2008. Pharmacological validation of a chronic social stress model of depression in rats:effects of reboxetine, haloperidol, and diazepam. Behav Pharmacol 19:183-196.
81. Sacchetti G, Bernini M, Bianchetti A, Parini S, Invernizzi RW, Samanin R. 1999. Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br J Pharmacol 128:1332-1338.
82. Savelyev SA, Rantamaki T, Rytkonen KM, Castren E, Porkka-Heiskanen T. 2012. Sleep homeostasis and depression: studies with the rat clomipramine model of depression. Neuroscience 212:149-158.
83. Schildkraut JJ. 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509-522.
84. Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R. 2006. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. Psychopharmacology 186:601-611.
85. Seu E, Lang A, Risvera RJ, Jentsch JD. 2009. Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys. Psychopharmacology 202:505-519.
86. Shakesby AC, Anwyl R, Rowan MJ. 2002. Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J Neurosci 22:3638-3644.
87. Shankaranarayana Rao BS, Raju TR. 2004a. Recording of extracellular field potential in the hippocampal slices. In: Raju TR, Kutty BM, Sathyaprabha TN, Shankaranarayana Rao BS, editors. Brain and behavior. Bangalore: National Institute of Mental Health and Neuro Sciences. p 115-118.
88. Shankaranarayana Rao BS, Raju TR. 2004b. The brain slice technique. In: Raju TR, Kutty BM, Sathyaprabha TN, Shankaranarayana Rao BS, editors. Brain and behavior. Bangalore: National Institute of Mental Health and Neuro Sciences. p 112-114.
89. Shankaranarayana Rao BS, Raju TR, Meti BL. 1998. Self-stimulation of lateral hypothalamus and ventral tegmentum increases the levels of noradrenaline, dopamine, glutamate, and AChE activity, but not 5-hydroxytryptamine and GABA levels in hippocampus and motor cortex. Neurochem Res 23:1053-1059.
90. Shankaranarayana Rao BS, Titus ADJ, Bhagya V, Srikumar BN, Deepti NV, Ramkumar K, Veena J, Raju TR. 2008a. Estimation of neurotransmitters in the rat brain by chromatographic methods. In: Shankaranarayana Rao BS, Subhash MN, Panicker MM, Srinivas Bharath MM, editors. Modern neurochemical techniques to understand brain functions. Bangalore: National Institute of Mental Health and Neuro Sciences. p 22-31.
91. Shankaranarayana Rao BS, Titus ADJ, Bhagya V, Srikumar BN, Deepti NV, Ramkumar K, Veena J, Raju TR. 2008b. Assay of acetylcholine esterase activity in the discrete regions of the rat brain. In: Shankaranarayana Rao BS, Subhash MN, Panicker MM, Srinivas Bharath MM, editors. Modern neurochemical techniques to understand brain functions. Bangalore: National Institute of Mental Health and Neuro Sciences. p 32-35.
92. Sheline YI, Gado MH, Kraemer HC. 2003. Untreated depression and hippocampal volume loss. Am J Psychiatry 160:1516-1518.
93. Shim SS, Hammonds MD, Ganocy SJ, Calabrese JR. 2007. Effects of subchronic lithium treatment on synaptic plasticity in the dentate gyrus of rat hippocampal slices. Prog Neuropsychopharmacol Biol Psychiatry 31:343-347.
94. Siepmann M, Muck-Weymann M, Joraschky P, Kirch W. 2001. The effects of reboxetine on autonomic and cognitive functions in healthy volunteers. Psychopharmacology 157:202-207.
95. Singh DP, Chopra K. 2013. Verapamil augments the neuroprotectant action of berberine in rat model of transient global cerebral ischemia. Eur J Pharmacol 720:98-106.
96. Srikumar BN, Raju TR, Shankaranarayana Rao BS. 2006. The involvement of cholinergic and noradrenergic systems in behavioral recovery following oxotremorine treatment to chronically stressed rats. Neuroscience 143:679-688.
97. Srikumar BN, Raju TR, Shankaranarayana Rao BS. 2007. Contrasting effects of bromocriptine on learning of a partially-baited radial arm maze task in the presence and absence of restraint stress. Psychopharmacology 193:363-374.
98. Srikumar BN, Priya V, Bhagya V, Veena J, Raju TR, Shankaranarayana Rao BS. 2008. Chronic oxotremorine treatment reverses stress-induced impairment of hippocampal long-term potentiation and spatial learning in rats. Soc Neurosci Abstr 38:282.14.
99. Steckler T, Rammes G, Sauvage M, van Gaalen MM, Weis C, Zieglgänsberger W, Holsboer F. 2001. Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice. J Psychiatr Res 35:29-42.
100. Stewart CA, Reid IC. 2000. Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology 148:217-223.
101. Straube T, Frey JU. 2003. Involvement of beta-adrenergic receptors in protein synthesis-dependent late long-term potentiation (LTP) in the dentate gyrus of freely moving rats: the critical role of the LTP induction strength. Neuroscience 119:473-479.
102. Straube T, Korz V, Balschun D, Frey JU. 2003. Requirement of beta-adrenergic receptor activation and protein synthesis for LTP-reinforcement by novelty in rat dentate gyrus. J Physiol 552:953-960.
103. Suarez-Lopez JR, Himes JH, Jacobs DR Jr, Alexander BH, Gunnar MR. 2013. Acetylcholinesterase activity and neurodevelopment in boys and girls. Pediatrics 132:e1649-1658.
104. Sunanda, Shankaranarayana Rao BS, Raju TR. 2000. Restraint stress-induced alterations in the levels of biogenic amines, amino acids, and AChE activity in the hippocampus. Neurochem Res 25:1547-1552.
105. Tiraboschi E, Tardito D, Kasahara J, Moraschi S, Pruneri P, Gennarelli M, Racagni G, Popoli M. 2004. Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 29:1831-1840.
106. Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M, McKinzie DL, Witkin JM, Nomikos GG. 2006. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine. Mol Psychiatry 11:187-195.
107. Valentini V, Cacciapaglia F, Frau R, Di Chiara G. 2006. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade. J Neurochem 98:113-121.
108. Veena J, Srikumar BN, Raju TR, Shankaranarayanas Rao BS. 2009a. Exposure to enriched environment restores the survival and differentiation of new born cells in the hippocampus and ameliorates depressive symptoms in chronically stressed rats. Neurosci Lett 455:178-182.
109. Veena J, Srikumar BN, Mahati K, Bhagya V, Raju TR, Shankaranarayana Rao BS. 2009b. Enriched environment restores hippocampal cell proliferation and ameliorates cognitive deficits in chronically stressed rats. J Neurosci Res 87:831-843.
110. Veena J, Srikumar BN, Mahati K, Raju TR, Shankaranarayana Rao BS. 2011. Oxotremorine treatment restores hippocampal neurogenesis and ameliorates behavioral depression in chronically stressed rats. Psychopharmacology 217:239-253.
111. Velázquez-Moctezuma J, Díaz RO. 1992. Neonatal treatment with clomipramine increased immobility in the forced swimming test: an attribute of animal models of depression. Pharmacol Biochem Behav 42:737-739.
112. Vijayakumar M, Meti BL. 1999. Alterations in the levels of monoamines in discrete brain regions of clomipramine-induced animal model of endogenous depression. Neurochem Res 24:345-349.
113. Vogel GW, Buffenstein A, Minter K, Hennessey A. 1990a. Drugs effects on REM sleep and endogenous depression. Neurosci Biobehav Rev 14:49-63.
114. Vogel G, Neill D, Hagler M, Kors D. 1990b. A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev 14:85-91.
115. Vogel G, Neill D, Hagler M, Kors D, Hartley P. 1990c. Decreased intracranial self-stimulation in a new animal model of depression. Neurosci Biobehav Rev 14:65-68.
116. Vogel G, Hagler M, Hennessey A, Richard C. 1996. Dose-dependent decrements in adult male rat sexual behavior after neonatal clomipramine treatment. Pharmacol Biochem Behav 54:605-609.
117. Vouimba RM, Muñoz C, Diamond DM. 2006. Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala. Stress 9:29-40.
118. Walling SG, Harley CW. 2004. Locus ceruleus activation initiates delayed synaptic potentiation of perforant path input to the dentate gyrus in awake rats: a novel beta-adrenergic- and protein synthesis-dependent mammalian plasticity mechanism. J Neurosci 24:598-604.
119. Wong EH, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP, Hyslop DK, Franklin S, Porsolt RD, Bonsignori A, Carfagna N, McArthur RA. 2000. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry 47:818-829.
120. Wyneken U, Sandoval M, Sandoval S, Jorquera F, Gonzalez I, Vargas F, Falcon R, Monari M, Orrego F. 2006. Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses. Neuropsychopharmacology 31:2415-2423.
121. Xu L, Anwyl R, Rowan MJ. 1997. Behavioral stress facilitates the induction of long-term depression in the hippocampus. Nature 387:497-500.
122. Yavari P, Vogel GW, Neill DB. 1993. Decreased raphe unit activity in a rat model of endogenous depression. Brain Res 611:31-36.